Zeria Pharmaceutical Co Ltd
TSE:4559
Zeria Pharmaceutical Co Ltd
Revenue
Zeria Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
Revenue
¥74.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Revenue
¥4.2T
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Revenue
¥1.5T
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Revenue
¥2T
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Revenue
¥1.1T
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
Astellas Pharma Inc
TSE:4503
|
Revenue
¥1.9T
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
See Also
What is Zeria Pharmaceutical Co Ltd's Revenue?
Revenue
74.6B
JPY
Based on the financial report for Dec 31, 2023, Zeria Pharmaceutical Co Ltd's Revenue amounts to 74.6B JPY.
What is Zeria Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was 13%. The average annual Revenue growth rates for Zeria Pharmaceutical Co Ltd have been 11% over the past three years , 4% over the past five years , and 2% over the past ten years .